Accessibility Menu
Park Ha Biological Technology logo

Park Ha Biological Technology(NASDAQ) BYAH

Market Cap$7.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)-100%
5 YearN/A
1 Year-99%
1 Month-13%
$3.00
+1.35%
+0.04Today
Park Ha Biological Technology last closing stock price
MetricPriceDate
Last closeUSD 3.002026-08-21
Park Ha Biological Technology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.37%USD 3.312026-08-14
1 month-12.79%USD 3.442026-07-22
3 month-65.28%USD 8.642026-05-22
Year to date-95.28%USD 63.602025-12-31
1 year-98.51%USD 202.002025-08-21
Since inception-99.82%USD 1,628.002024-12-27

Park Ha Biological Technology Financials at a Glance

Market Cap

$7.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.82M

Net Income (TTM)

-$8.17M

EPS (TTM)

-$62.38

P/E Ratio

-0.05

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$3.00

Volume

69,091.994

Open

$3.04

Previous Close

$3.00

Daily Range

$2.85 - $3.08

52-Week Range

$2.56 - $254.70

Estimated Earnings Date

N/A

BYAH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Park Ha Biological Technology

Park Ha Biological Technology Co., Ltd. is a biotechnology firm dedicated to developing innovative solutions to address global health challenges. The company's focus on research and development, along with strategic partnerships, drives its competitive edge in the biotech industry.

Products and Services

Biotechnological products aimed at advancing global health.

Research and development services leveraging cutting-edge technologies.

Strategic alliances for broader distribution and market entry.

What Makes Park Ha Biological Technology Co., Ltd. Special

Park Ha Biological Technology Co., Ltd. differentiates itself through a commitment to innovation supported by a strong research and development focus and a robust intellectual property portfolio. Its experienced leadership team and strategic partnerships with leading research institutions further enhance its position in the biotech sector.

Five Things You Need to Know

The company focuses on research and development to drive innovation in biotechnology.

The leadership team has extensive experience in the biotechnology and pharmaceutical industries.

Strategic partnerships enhance its competitive position in the biotech space.

The company is committed to sustainability and ethical practices.

Expanding product pipeline and exploring new therapeutic areas are central to its growth strategy.

AI Generated • Apr 16, 2026

Industry

Specialty Retail

Sector

Consumer Discretionary

Employees

41

CEO

Xiao Qiu Zhang

Website

www.parkha.cn

Headquarters

Wuxi, JS 214100, CN

BYAH Financials

Key Financial Metrics (TTM)

Gross Margin

89.94%

Operating Margin

-212.16%

Net Income Margin

-214.17%

Return on Equity

-174.17%

Return on Capital

-578.41%

Return on Assets

-109.51%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.35M

Volume

69.09K

Avg. Volume

901.54K

Financials (TTM)

Gross Profit

$3.43M

Operating Income

-$8.09M

EBITDA

-$7.80M

Operating Cash Flow

-$409.96K

Capital Expenditure

-$467.51K

Free Cash Flow

-$877.47K

Cash & ST Invst.

$5.66M

Total Debt

$186.33K

Park Ha Biological Technology Performance Analysis

Park Ha Biological Technology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31USD 1,919,389N/A
20232023-10-31USD 2,459,10228.1%
20242024-10-31USD 2,381,851-3.1%
20252025-10-31USD 2,524,8436.0%
Park Ha Biological Technology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31-48.1%
Q42025-10-31100.0%
Q12026-01-31-51.1%
Q22026-04-30100.0%
Park Ha Biological Technology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31USD 2.60N/A
20232023-10-31USD 11.60345.6%
20242024-10-31USD 6.52-43.8%
20252025-10-31USD -331.00N/A
Park Ha Biological Technology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-3189.5%
Q42025-10-31-115.0%
Q12026-01-3197.9%
Q22026-04-30-18.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.26M

+1.5%

Gross Profit

$1.12M

-5.4%

Gross Margin

88.79%

N/A

Market Cap

$7.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$171.62K

N/A

Employees

41

N/A

Net Income

-$918.28K

+95.4%

EBITDA

-$867.27K

+95.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$5.66M

+318.7%

Total Debt

$186.33K

+103.7%

Accounts Receivable

$930.53K

-77.6%

Inventory

$115.32K

+75.2%

Long Term Debt

$57.90K

-8.2%

Short Term Debt

$128.43K

+352.2%

Return on Assets

-1.10%

N/A

Return on Invested Capital

-1.49%

N/A

Free Cash Flow

-$338.79K

-239.3%

Operating Cash Flow

-$113.73K

-146.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CGTLCreative Global Technology Holdings Limited Ordinary Shares
$4.72-1.67%
PMNTPerfect Moment Ltd. Common Stock
$0.14+27.27%
AZIAutozi Internet Technology (Global) Ltd.
$1.45+0.69%
BTBDBT Brands, Inc.
$1.31+3.97%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About BYAH

What is the current price of Park Ha Biological Technology?

Park Ha Biological Technology is trading at $3.00 per share.

What is the 52-week range for Park Ha Biological Technology?

Over the past 52 weeks, Park Ha Biological Technology has traded between $2.56 and $254.70.

How much debt does Park Ha Biological Technology have?

As of the most recent reporting period, Park Ha Biological Technology reported total debt of $180.17K.

How much cash does Park Ha Biological Technology have on hand?

Park Ha Biological Technology reported $3.79M in cash and cash equivalents in its most recent financial results.

What is Park Ha Biological Technology’s dividend yield?

Park Ha Biological Technology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services